• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纽约皇后区埃尔姆赫斯特医院中心对孕妇进行 SARS-CoV-2 感染的普遍筛查。

Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York.

机构信息

Department of Health System Design and Global Health and the Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai, New York City, NY, United States of America.

Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai, New York City, NY, United States of America.

出版信息

PLoS One. 2020 Dec 10;15(12):e0238409. doi: 10.1371/journal.pone.0238409. eCollection 2020.

DOI:10.1371/journal.pone.0238409
PMID:33301498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7728244/
Abstract

BACKGROUND

Universal screening for SARS-CoV-2 infection on Labor and Delivery (L&D) units is a critical strategy to manage patient and health worker safety, especially in a vulnerable high-prevalence community. We describe the results of a SARS-CoV-2 universal screening program at the L&D Unit at Elmhurst Hospital in Queens, NY, a 545-bed public hospital serving a diverse, largely immigrant and low-income patient population and an epicenter of the global pandemic.

METHODS AND FINDINGS

We conducted a retrospective cross-sectional study. All pregnant women admitted to the L&D Unit of Elmhurst Hospital from March 29, 2020 to April 22, 2020 were included for analysis. The primary outcomes of the study were: (1) SARS-CoV-2 positivity among universally screened pregnant women, stratified by demographic characteristics, maternal comorbidities, and delivery outcomes; and (2) Symptomatic or asymptomatic presentation at the time of testing among SARS-CoV-2 positive women. A total of 126 obstetric patients were screened for SARS-CoV-2 between March 29 and April 22. Of these, 37% were positive. Of the women who tested positive, 72% were asymptomatic at the time of testing. Patients who tested positive for SARS-CoV-2 were more likely to be of Hispanic ethnicity (unadjusted difference 24.4 percentage points, CI 7.9, 41.0) and report their primary language as Spanish (unadjusted difference 32.9 percentage points, CI 15.8, 49.9) than patients who tested negative.

CONCLUSIONS

In this retrospective cross-sectional study of data from a universal SARS-Cov-2 screening program implemented in the L&D unit of a safety-net hospital in Queens, New York, we found over one-third of pregnant women testing positive, the majority of those asymptomatic. The rationale for universal screening at the L&D Unit at Elmhurst Hospital was to ensure safety of patients and staff during an acute surge in SARS-Cov-2 infections through appropriate identification and isolation of pregnant women with positive test results. Women were roomed by their SARS-CoV-2 status given increasing space limitations. In addition, postpartum counseling was tailored to infection status. We quickly established discharge counseling and follow-up protocols tailored to their specific social needs. The experience at Elmhurst Hospital is instructive for other L&D units serving vulnerable populations and for pandemic preparedness.

摘要

背景

在分娩(L&D)病房进行 SARS-CoV-2 感染的普遍筛查是管理患者和卫生工作者安全的关键策略,尤其是在高危高发病率社区。我们描述了纽约皇后区埃尔姆赫斯特医院 L&D 病房 SARS-CoV-2 普遍筛查计划的结果,该医院是一家拥有 545 张床位的公立医院,服务于多样化的、主要是移民和低收入患者群体,也是全球大流行的中心。

方法和发现

我们进行了一项回顾性横断面研究。所有于 2020 年 3 月 29 日至 4 月 22 日期间入住埃尔姆赫斯特医院 L&D 病房的孕妇均纳入分析。该研究的主要结果是:(1)根据人口统计学特征、产妇合并症和分娩结果,对普遍筛查的孕妇进行 SARS-CoV-2 阳性率分层;(2)SARS-CoV-2 阳性妇女在检测时的症状或无症状表现。在 3 月 29 日至 4 月 22 日期间,共对 126 名产科患者进行了 SARS-CoV-2 筛查。其中,37%呈阳性。在检测呈阳性的女性中,72%在检测时无症状。检测呈 SARS-CoV-2 阳性的患者更有可能是西班牙裔(未调整差异 24.4 个百分点,CI 7.9,41.0),并且报告其主要语言为西班牙语(未调整差异 32.9 个百分点,CI 15.8,49.9),而检测呈阴性的患者则较少。

结论

在这项对纽约皇后区一家安全网医院 L&D 病房实施的 SARS-CoV-2 普遍筛查计划数据的回顾性横断面研究中,我们发现超过三分之一的孕妇检测呈阳性,其中大多数为无症状。埃尔姆赫斯特医院 L&D 病房进行普遍筛查的基本原理是通过适当识别和隔离检测结果阳性的孕妇,确保在 SARS-CoV-2 感染急剧增加期间患者和工作人员的安全。根据 SARS-CoV-2 检测结果为患者安排病房。此外,对产后护理进行了针对性调整以适应感染状况。我们迅速制定了符合其特定社会需求的出院咨询和随访方案。埃尔姆赫斯特医院的经验为服务于弱势群体的其他 L&D 病房和大流行防范提供了借鉴。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd77/7728244/c914f337a375/pone.0238409.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd77/7728244/c410cabc593e/pone.0238409.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd77/7728244/c914f337a375/pone.0238409.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd77/7728244/c410cabc593e/pone.0238409.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd77/7728244/c914f337a375/pone.0238409.g002.jpg

相似文献

1
Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York.纽约皇后区埃尔姆赫斯特医院中心对孕妇进行 SARS-CoV-2 感染的普遍筛查。
PLoS One. 2020 Dec 10;15(12):e0238409. doi: 10.1371/journal.pone.0238409. eCollection 2020.
2
Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.莫桑比克孕妇和产后妇女感染 SARS-CoV-2 的临床和流行病学特征:一项前瞻性队列研究。
Reprod Health. 2022 Jul 19;19(1):164. doi: 10.1186/s12978-022-01469-9.
3
Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.住院孕妇普遍进行严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测项目的结果及肺部超声在筛查中的辅助作用:一项前瞻性队列研究
J Matern Fetal Neonatal Med. 2020 Nov;33(22):3820-3826. doi: 10.1080/14767058.2020.1798398. Epub 2020 Jul 28.
4
Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization.在大型管理式医疗组织中,对入院分娩的女性进行普遍的 SARS-CoV-2 筛查。
Am J Perinatol. 2020 Sep;37(11):1110-1114. doi: 10.1055/s-0040-1714060. Epub 2020 Jul 3.
5
Routine screening for SARS CoV-2 in unselected pregnant women at delivery.对分娩的未选择孕妇进行常规 SARS-CoV-2 筛查。
PLoS One. 2020 Sep 29;15(9):e0239887. doi: 10.1371/journal.pone.0239887. eCollection 2020.
6
Temporal Trend in SARS-CoV-2 Symptoms in Pregnant Women.孕妇感染 SARS-CoV-2 症状的时间趋势。
Am J Perinatol. 2023 Aug;40(11):1259-1264. doi: 10.1055/s-0041-1739490. Epub 2021 Dec 16.
7
Screening and Testing Pregnant Patients for SARS-CoV-2: First-Wave Experience of a Designated COVID-19 Hospitalization Centre in Montréal.对 SARS-CoV-2 感染孕妇进行筛查和检测:蒙特利尔指定 COVID-19 住院中心的第一波经验。
J Obstet Gynaecol Can. 2021 May;43(5):571-575. doi: 10.1016/j.jogc.2020.11.001. Epub 2020 Nov 5.
8
The Psychological Experience of Obstetric Patients and Health Care Workers after Implementation of Universal SARS-CoV-2 Testing.实施普遍 SARS-CoV-2 检测后,产科患者和医护人员的心理体验。
Am J Perinatol. 2020 Oct;37(12):1271-1279. doi: 10.1055/s-0040-1715505. Epub 2020 Aug 5.
9
Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.在费城的 2 家医院进行的严重急性呼吸综合征冠状病毒 2 通用检测:2 周内的携带者流行率和症状发展。
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100226. doi: 10.1016/j.ajogmf.2020.100226. Epub 2020 Sep 11.
10
Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, Mexico.墨西哥城一家三级护理中心进行普遍筛查的结果:有或无症状轻症/中度症状的孕妇中 SARS-CoV-2 感染的流行率、临床特征和结局。
PLoS One. 2021 Apr 22;16(4):e0249584. doi: 10.1371/journal.pone.0249584. eCollection 2021.

引用本文的文献

1
Post-discharge Care Practices, Challenges, and Outcomes in Newborn Infants of Mothers With SARS-CoV-2 Infection: Insights From Public Hospitals.感染新冠病毒的母亲所生新生儿出院后的护理实践、挑战及结局:来自公立医院的见解
Cureus. 2024 Apr 22;16(4):e58734. doi: 10.7759/cureus.58734. eCollection 2024 Apr.
2
Universal Screening for SARS-CoV-2 in Obstetric Care: Clinical Characteristics and Maternofetal Outcomes in a Latin American High-Complexity Unit.产科护理中对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进行普遍筛查:拉丁美洲一个高复杂性科室的临床特征及母婴结局
J Patient Exp. 2023 Nov 15;10:23743735231213764. doi: 10.1177/23743735231213764. eCollection 2023.
3

本文引用的文献

1
Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers.在纽约市五家医疗中心,241 例严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染产妇的特征和结局。
Obstet Gynecol. 2020 Aug;136(2):273-282. doi: 10.1097/AOG.0000000000004025.
2
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.COVID-19 感染的产科患者的症状和重症。
Obstet Gynecol. 2020 Aug;136(2):291-299. doi: 10.1097/AOG.0000000000003996.
3
Clinical Implications of Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Pregnancy.
Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 Polymerase Chain Reaction Screening: A Cost-Utility Analysis.
普遍无症状术前SARS-CoV-2聚合酶链反应筛查的成本效益:一项成本效用分析。
Clin Infect Dis. 2024 Jan 25;78(1):57-64. doi: 10.1093/cid/ciad463.
4
COVID-19 on Pregnancy Outcomes, Mental Health and Placenta: Focus in Latin America.COVID-19 对妊娠结局、心理健康和胎盘的影响:关注拉丁美洲。
Adv Exp Med Biol. 2023;1428:269-285. doi: 10.1007/978-3-031-32554-0_12.
5
Inflammatory-Metal Profile as a Hallmark for COVID-19 Severity During Pregnancy.炎症-金属谱作为孕期COVID-19严重程度的标志
Front Cell Dev Biol. 2022 Aug 9;10:935363. doi: 10.3389/fcell.2022.935363. eCollection 2022.
6
Establishing a Universal RT-PCR Testing System Is Essential for the Safe Performance of Scheduled Surgeries During the COVID-19 Pandemic in Japan: A Retrospective Study.建立通用逆转录聚合酶链反应检测系统对于日本新冠疫情期间择期手术的安全开展至关重要:一项回顾性研究。
Cureus. 2022 Jun 15;14(6):e25974. doi: 10.7759/cureus.25974. eCollection 2022 Jun.
7
Prevalence of SARS-CoV-2 infection among obstetric patients in Ottawa, Canada: a descriptive study.加拿大渥太华地区产科患者中 SARS-CoV-2 感染的流行情况:一项描述性研究。
CMAJ Open. 2022 Jul 12;10(3):E643-E651. doi: 10.9778/cmajo.20210228. Print 2022 Jul-Sep.
8
Impact of SARS-CoV-2 infection on risk of prematurity, birthweight and obstetric complications: A multivariate analysis from a nationwide, population-based retrospective cohort study.SARS-CoV-2 感染对早产、出生体重和产科并发症风险的影响:一项基于全国性、人群回顾性队列研究的多变量分析。
BJOG. 2022 Jun;129(7):1084-1094. doi: 10.1111/1471-0528.17135. Epub 2022 Apr 15.
9
Universal Testing Policy for COVID-19 in Pregnancy: A Systematic Review.COVID-19 孕期通用检测政策:系统评价。
Front Public Health. 2022 Feb 8;10:588269. doi: 10.3389/fpubh.2022.588269. eCollection 2022.
10
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia).德国弗兰肯地区通过逆转录聚合酶链反应评估的孕妇中严重急性呼吸综合征冠状病毒2的流行情况:情景研究(弗兰肯地区孕期及分娩时严重急性呼吸综合征冠状病毒2的流行情况)的初步结果
Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):226-234. doi: 10.1055/a-1727-9672. eCollection 2022 Feb.
孕期普遍进行严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测的临床意义。
Obstet Gynecol. 2020 Aug;136(2):232-234. doi: 10.1097/AOG.0000000000003983.
4
Testing of Patients and Support Persons for Coronavirus Disease 2019 (COVID-19) Infection Before Scheduled Deliveries.对计划分娩前的患者和支持人员进行 2019 年冠状病毒病(COVID-19)感染检测。
Obstet Gynecol. 2020 Aug;136(2):283-287. doi: 10.1097/AOG.0000000000003985.
5
Screening all pregnant women admitted to labor and delivery for the virus responsible for coronavirus disease 2019.对所有入住产科进行分娩的孕妇进行2019冠状病毒病致病病毒筛查。
Am J Obstet Gynecol. 2020 Aug;223(2):284-286. doi: 10.1016/j.ajog.2020.04.024. Epub 2020 Apr 26.
6
Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs.纽约市各行政区的 COVID-19 住院和死亡情况存在差异。
JAMA. 2020 Jun 2;323(21):2192-2195. doi: 10.1001/jama.2020.7197.
7
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.对入院分娩的女性进行新冠病毒2型普遍筛查。
N Engl J Med. 2020 May 28;382(22):2163-2164. doi: 10.1056/NEJMc2009316. Epub 2020 Apr 13.
8
Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020.2020 年 1 月 23 日至 3 月 16 日新加坡出现的 SARS-CoV-2 病前传播。
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415. doi: 10.15585/mmwr.mm6914e1.
9
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.估算 2020 年日本横滨钻石公主号游轮上的 2019 年冠状病毒病(COVID-19)病例的无症状比例。
Euro Surveill. 2020 Mar;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.2000180.